Graf Akcie ACOR (Acorda Therapeutics Inc). Diskuze k akciím ACOR. Aktuální informace ACOR.

Základní informace o společnosti Acorda Therapeutics Inc (Akcie ACOR)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 52.06M
Hodnota podniku (EV) 167.2M
Tržby 151.897M
EBITDA -50.69
Zisk -132.02
Růst v tržbách Q/Q -5.45 %
Růst v tržbách Y/Y -5.03 %
P/E (Cena vůči ziskům) N/A
Forward P/E -0.21
EV/Sales 1.10
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 0.34
P/FCF N/A
Price/Book 0.22
Účetní hodnota na akcii 22.26
Hotovost na akcii 9.63
FCF vůči ceně -71.77 %
Počet zaměstnanců 168
Tržba na zaměstnance 904.149k
Profit margin -65.11 %
Operating margin -91.76 %
Gross margin 78.09 %
EBIT margin -69.98 %
EBITDA margin -33.37 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst -10.95 %
EPS - Očekávaný růst příští rok 13.04 %
Return on assets -21.83 %
Return on equity -55.69 %
ROIC -10.76 %
ROCE -25.08 %
Dluhy/Equity 1.66
Čistý dluh/EBITDA -10.51
Current ratio 1.67
Quick Ratio 1.29
Volatilita 5.45
Beta 0.70
RSI 62.91
Cílová cena analytiků 2
Známka akcie (dle analytiků) 2.33
Insider ownership 1.85 %
Institutional ownership 39.92 %
Počet akcií 11.124M
Procento shortovaných akcií 15.38 %
Short ratio 9.28 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2006
Země United States

Finanční výsledky akcie ACOR

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$192.408$471.433$588.287$519.601$492.66$401.48
Cost Of Goods Sold$34.849$97.64$111.956$108.109$92.931$80.615
Gross Profit$157.559$373.793$476.331$411.492$399.729$320.865
Research And Development Expenses$60.083$106.383$166.105$203.437$149.209$73.47
SG&A Expenses$192.846$172.254$181.619$235.437$205.63$201.813
Other Operating Income Or Expenses$86.935$-55$-40.9$-8.6$-10.9$-9.191
Operating Expenses$504.04$432.947$821.101$555.583$458.67$365.089
Operating Income$-311.632$38.486$-232.814$-35.982$33.99$36.391
Total Non-Operating Income/Expense$37.384$-18.063$-19.071$-6.286$-14.621$-8.382
Pre-Tax Income$-274.248$20.423$-251.885$-42.268$19.369$28.009
Income Taxes$-1.282$-13.259$-28.526$-6.665$8.311$10.337
Income After Taxes$-272.966$33.682$-223.359$-35.603$11.058$17.672
Other Income------
Income From Continuous Operations$-272.966$33.682$-223.359$-35.603$11.058$17.672
Income From Discontinued Operations------
Net Income$-272.966$33.682$-223.359$-34.618$11.058$17.672
EBITDA$14.579$64.37$99.336$-4.216$60.93$52.753
EBIT$-311.632$38.486$-232.814$-35.982$33.99$36.391
Basic Shares Outstanding888877
Shares Outstanding888877
Basic EPS$-34.49$4.32$-29.15$-4.56$1.56$2.58
EPS - Earnings Per Share$-34.49$4.26$-29.15$-4.56$1.50$2.52
# 2020 2019 2018 2017 2016 2015
Current Ratio2.32813.76533.06821.84354.98193.4159
Long-term Debt / Capital0.41250.35930.39140.32790.32590.3492
Debt/Equity Ratio0.70420.56170.64450.49730.48350.5387
Gross Margin81.88879.288780.969279.193881.136979.9205
Operating Margin-161.96418.1636-39.5749-6.92496.89939.0642
EBIT Margin-161.96418.1636-39.5749-6.92496.89939.0642
EBITDA Margin7.577113.654116.8856-0.811412.367613.1396
Pre-Tax Profit Margin-142.53464.3321-42.8167-8.13473.93156.9764
Net Profit Margin-141.86837.1446-37.9677-6.66242.24464.4017
Asset Turnover0.24060.36270.49110.38710.44330.377
Inventory Turnover Ratio1.38173.36532.98542.50632.54773.0039
Receiveable Turnover8.712920.12097.22689.946615.656912.4641
Days Sales In Receivables41.891718.140350.506136.695923.312429.2842
ROE - Return On Equity-87.82135.5037-42.9547-5.36021.83383.271
Return On Tangible Equity298.2941-34.1443113.24979.9275-96.4324-23.4007
ROA - Return On Assets-34.13282.5916-18.6448-2.65230.99511.6592
ROI - Return On Investment-51.59173.5265-26.1403-3.60271.23612.1288
Book Value Per Share39.088177.416867.189687.249384.151677.3779
Operating Cash Flow Per Share-35.28996.448.7379-1.3621-5.23384.8719
Free Cash Flow Per Share-42.48384.00197.7735-1.3686-5.33114.7368

Porovnání s konkurencí: Akcie ACOR

Společnost P/E PEG Růst v tržbách (roční) Růst v EPS Return on equity P/B Profit margin
ACOR N/A N/A -5.03 % 13.04 % -55.69 % 0.22 -65.11 %
Akcie BMRN 16.78 2.77 3.76 % -105.99 % 20.22 % 3.42 46.18 %
Akcie MNTA N/A 0.10 -55.12 % -2.22 % -58.65 % 13.74 N/A %
Akcie MYL 32.42 0.68 1.11 % -2.86 % 2.25 % 0.72 N/A %
Akcie RGEN 145.78 3.82 68.12 % 60.00 % 6.88 % 9.64 16.36 %
Akcie RGEN 145.78 3.82 68.12 % 60.00 % 6.88 % 9.64 16.36 %

Nedávné obchody insiderů: Akcie ACOR

Jméno Obchod Cena Objem
Capital Management Lp Scopi...
Prodej
15 Jan 2019
$16.93 $1,580,416
Capital Management Lp Scopi...
Prodej
17 Jan 2019
$16.68 $2,324,491
Capital Management Lp Scopi...
Prodej
22 Jan 2019
$16.01 $1,566,466
Capital Management Lp Scopi...
Prodej
24 Jan 2019
$16.02 $176,236
Capital Management Lp Scopi...
Prodej
30 Jan 2019
$16.01 $112,070
David Lawrence
Chief, Bus. Ops, and PAO
Prodej
22 Feb 2019
$13.18 $10,030
Lauren M Sabella
Chief Commercial Officer
Prodej
22 Feb 2019
$13.18 $10,030
Ron Cohen
President and CEO
Prodej
2 Dec 2019
$1.60 $7,518
David Lawrence
Chief, Bus. Ops, and PAO
Prodej
2 Dec 2019
$1.60 $1,882
Lauren M Sabella
Chief Commercial Officer
Prodej
2 Dec 2019
$1.60 $2,421
Jane Wasman
President, Intl, and GC
Prodej
2 Dec 2019
$1.60 $3,563

Diskuze k akciím ACOR